Older Adults, Methadone, and Cognitive Function
Cognitive Functioning Among Older Adults in Methadone Treatment for Opioid Use Disorder
1 other identifier
interventional
30
1 country
1
Brief Summary
The increasing prevalence of opioid use disorder (OUD) among older adults, coupled with high overdose rates and cognitive impairments associated with opioid use, highlights a critical gap in addiction treatment. Cognitive impairments can persist despite treatment and negatively impact recovery outcomes, yet cognitive screening and interventions are rarely integrated into OUD care. This study aims to evaluate the feasibility of remotely delivered, smartphone-based cognitive assessments (administered through NeuroUX web-based software) for older adults (55+) in methadone treatment. The tasks have been "gamified" to make them engaging and brief, which could be appealing to patients. They will complete the tasks for 15 days using the phone provided or their own phone. During days 6-15 of testing, tasks will become incrementally more difficult based on participant performance to assess the feasibility of cognitive training. Cognitive training uses engaging games or tasks to strengthen thinking skills like memory and focus, much like physical exercise strengthens the body. Adherence, acceptability, and usability of the tasks will be assessed. Secondary analyses will explore relationships between task performance and participant characteristics (e.g., baseline cognitive functioning, methadone dose, timing of methadone dose). Findings from this pilot study will provide foundational data for a future grant application to develop and test digital cognitive assessment and training interventions tailored to older adults in addiction treatment. By addressing a critical yet understudied aspect of OUD care this research has the potential to enhance treatment engagement, improve clinical outcomes, and support long-term recovery in the growing older population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 25, 2025
CompletedFirst Posted
Study publicly available on registry
September 3, 2025
CompletedStudy Start
First participant enrolled
December 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 15, 2027
February 27, 2026
February 1, 2026
11 months
August 25, 2025
February 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Adherence to smartphone task completion
proportion of completed assessments on the smartphone
across 15 days of use
Satisfaction with smartphone tasks
Proportion reporting high satisfaction (\>70%) with smartphone tasks
across 15 days of use
Usability of smartphone tasks
mean score \> 68 on the "System Usability Scale" a reliable, low-cost usability scale that can be used for global assessments of systems usability. Higher scores indicate greater usability.
after 15 days of use
Cognitive Task Performance
Performance on each of 3 cognitive tasks will be assessed for each time a task is completed. Performance will be compared across days of use.
15 days of smartphone tasks
Secondary Outcomes (1)
Laboratory cognitive functioning
1 month (pre-post 15 day cognitive tasks on smartphone)
Other Outcomes (1)
Montreal Cognitive Asesssment (MOCA) (baseline cognitive performance)
Baseline assessment (before 15 days of smartphone task completion)
Study Arms (1)
Smartphone-based assessments and cognitive tasks
EXPERIMENTALAll participants will complete a baseline session to colelct data related to demographics, health history/status, and cognitive functioning. Participants will be oriented to the smartphone application which is delivered via NeuroUX cloud-based technology which send a text message to the smartphone as a prompt for tasks which will be administered across 15 days. All participants complete the same tasks and duration of tasks. Then all participants complete a follow-up assessment to examine their preferences related to the smartphone and cognitive function.
Interventions
15 days Smartphone/Cellphone tasks: Using NeuroUX smartphone testing software, Cognitive "games"/tasks lasting approximately 3-4 minutes each will be administered through the a smartphone application and will be prompted via text message twice per day across 15 consecutive days in the morning (8-11am) and evening (5-8). Tasks were chosen to measure aspects of diverse aspects of cognitive that are impaired among patients taking methadone, including N-back task (working memory), the Stroop Task (executive function/cognitive control), and the Variable Difficulty List Memory Test (learning and memory). The 15 days will include two types of task administration: a) Testing Phase: tasks administered at a consistent, fixed difficulty level (days 1-5) b) Remediation Phase: increasing task difficulty in response to participant performance (days 6-15). To encourage adherence, researchers will contact participants to remind them of task completion.
Eligibility Criteria
You may qualify if:
- age 55 and older
- currently in outpatient methadone treatment for opioid use disorder
- participant is alert/able to communicate/able to give acceptable answers on the "Evaluation to Sign Consent form
- participant has normal or correct to normal vision
You may not qualify if:
- age 54 or younger
- not in methadone treatment for opioid use disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UM Addiction Treatment Programs at 1001 West Pratt
Baltimore, Maryland, 21124, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, Psychiatry, University of Maryland School of Medicine
Study Record Dates
First Submitted
August 25, 2025
First Posted
September 3, 2025
Study Start
December 3, 2025
Primary Completion (Estimated)
October 31, 2026
Study Completion (Estimated)
January 15, 2027
Last Updated
February 27, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Start date: date when study is completed and data analyses are completed End date: 5 years from date of study completion and data analyses completed
- Access Criteria
- Request sent to Principal Investiagator and approved by Principal Investigator
De-identified individual participant data, including baseline characteristics and outcome measures, will be shared with qualified researchers upon request. Data will be available after publication of the primary results. Requests will require approval by the principal investigator.